Award details

PeriTune - a clonal optimisation platform

ReferenceBB/M011259/1
Principal Investigator / Supervisor Dr Neil Dixon
Co-Investigators /
Co-Supervisors
Institution The University of Manchester
DepartmentLife Sciences
Funding typeResearch
Value (£) 121,512
StatusCompleted
TypeResearch Grant
Start date 01/04/2015
End date 31/03/2016
Duration12 months

Abstract

The aim of this collaboratory Early Stage Feasibility project is to develop a protein expression optimisation platform for the robust production of biologics. This platform will enable key bottlenecks and manufacturability challenges of recombinant proteins used in Industrial Biotechnology to be addressed. The platform will utilize the tuneable gene expression control technology RiboTite, developed at the University of Manchester. This technology operates at the level of translation initiation and permits cellular-level tuneable control of gene expression. Clones developed through the optimisation platform will be validated, demonstrated at scale, and assessed for manufacturability.

Summary

A variety of micro-organisms including E. coli and S. cerevisiae (baker's yeast), are used in commercial bio-production processes to manufacture a number of products, ranging from high-value low-volume products, such bio-therapeutics (e.g. recombinant insulin), to mid-value products, (e.g. biocatalysts and specialised chemicals), to low-value bulk commodity products (e.g. succinic acid and biofuels). This project will seek to develop a robust clone optimsiation platform for the potential use and application in the above industrial sectors, and so would be of great benefit in a number of applied and fundamental areas of biological and biomedical R&D.

Impact Summary

As described in proposal submitted to TSB
Committee Not funded via Committee
Research TopicsIndustrial Biotechnology, Microbiology, Synthetic Biology
Research PriorityX – Research Priority information not available
Research Initiative Industrial Biotechnology Catalyst (IBCAT) [2014-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file